BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 22858277)

  • 21. Outcome of heart transplantation after bridge-to-transplant strategy using various mechanical circulatory support devices.
    Yoshioka D; Li B; Takayama H; Garan RA; Topkara VK; Han J; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K
    Interact Cardiovasc Thorac Surg; 2017 Dec; 25(6):918-924. PubMed ID: 29106559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of total artificial heart and biventricular assist device support as bridge-to-transplantation.
    Cheng A; Trivedi JR; Van Berkel VH; Massey HT; Slaughter MS
    J Card Surg; 2016 Oct; 31(10):648-653. PubMed ID: 27573150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporary left ventricular assist devices as a bridge to heart transplantation.
    Seese L; Hickey G; Keebler ME; Mathier MA; Sultan I; Gleason TG; Wang Y; Kilic A
    J Card Surg; 2020 Apr; 35(4):810-817. PubMed ID: 32092194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
    Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
    J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registry.
    Patlolla V; Patten RD; Denofrio D; Konstam MA; Krishnamani R
    J Am Coll Cardiol; 2009 Jan; 53(3):264-71. PubMed ID: 19147043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time.
    Dardas T; Mokadam NA; Pagani F; Aaronson K; Levy WC
    J Am Coll Cardiol; 2012 Jul; 60(1):36-43. PubMed ID: 22541833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.
    Truby LK; Farr MA; Garan AR; Givens R; Restaino SW; Latif F; Takayama H; Naka Y; Takeda K; Topkara VK
    Circulation; 2019 Aug; 140(6):459-469. PubMed ID: 31203669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9-Year Experience.
    Morgan JA; Go PH; Xuereb L; Kaur B; Akrawe S; Nemeh HW; Borgi J; Lanfear DE; Williams CT; Paone G
    Ann Thorac Surg; 2016 Oct; 102(4):1266-73. PubMed ID: 27173072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure.
    Schumer EM; Ising MS; Trivedi JR; Slaughter MS; Cheng A
    Ann Thorac Surg; 2015 Aug; 100(2):522-7. PubMed ID: 26070601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should orthotopic heart transplantation using marginal donors be limited to higher volume centers?
    Kilic A; Weiss ES; Allen JG; George TJ; Yuh DD; Shah AS; Conte JV
    Ann Thorac Surg; 2012 Sep; 94(3):695-702. PubMed ID: 22626758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation.
    Oliveira GH; Hardaway BW; Kucheryavaya AY; Stehlik J; Edwards LB; Taylor DO
    J Heart Lung Transplant; 2012 Aug; 31(8):805-10. PubMed ID: 22551930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential impact on post-transplant outcomes between pulsatile- and continuous-flow left ventricular assist devices.
    Ventura PA; Alharethi R; Budge D; Reid BB; Horne BD; Mason NO; Stoker S; Caine WT; Rasmusson B; Doty J; Clayson SE; Kfoury AG
    Clin Transplant; 2011; 25(4):E390-5. PubMed ID: 21401721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved survival after heart transplantation in patients with bridge to transplant in the recent era: a 17-year single-center experience.
    Osaki S; Edwards NM; Johnson MR; Velez M; Munoz A; Lozonschi L; Murray MA; Proebstle AK; Kohmoto T
    J Heart Lung Transplant; 2009 Jun; 28(6):591-7. PubMed ID: 19481020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender differences in continuous-flow left ventricular assist device therapy as a bridge to transplantation: a risk-adjusted comparison using a propensity score-matching analysis.
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; García Sáez D; Amrani M; Bahrami T; De Robertis F; Wahlers T; Banner NR; Popov AF; Simon AR
    Artif Organs; 2015 Mar; 39(3):212-9. PubMed ID: 25175547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of recipient body mass index on organ allocation and mortality in orthotopic heart transplantation.
    Weiss ES; Allen JG; Russell SD; Shah AS; Conte JV
    J Heart Lung Transplant; 2009 Nov; 28(11):1150-7. PubMed ID: 19782581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes in bicaval versus biatrial techniques in heart transplantation: an analysis of the UNOS database.
    Weiss ES; Nwakanma LU; Russell SB; Conte JV; Shah AS
    J Heart Lung Transplant; 2008 Feb; 27(2):178-83. PubMed ID: 18267224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modern Outcomes of Mechanical Circulatory Support as a Bridge to Pediatric Heart Transplantation.
    Wehman B; Stafford KA; Bittle GJ; Kon ZN; Evans CF; Rajagopal K; Pietris N; Kaushal S; Griffith BP
    Ann Thorac Surg; 2016 Jun; 101(6):2321-7. PubMed ID: 26912304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.